Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms × apalutamide × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 57 Neoplasm Metastasis 3 Stage II Prostate Adenocarcinoma 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Prostate Cancer With ≤10 Bone Metastases 1 Prostate Cancer Metastatic Disease 1 Prostate Cancer Metastatic 1 Prostate Adenocarcinoma 1 Patient Preference 1 Non-Muscle Invasive Bladder Urothelial Carcinoma 1 Neoplasms 1 Neoadjuvant Therapy 1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-sensitive Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Low Risk Prostate Cancer 1 High-Risk and Oligometastatic Prostate Cancer 1 High Risk Prostate Cancer 1 Hematologic Neoplasms 1 Genital Diseases, Male 1 Castration Levels of Testosterone 1 Carcinoma, Small Cell 1 Bulbo-Spinal Atrophy, X-Linked 1 Advanced Prostate Carcinoma 1

Interventions

Surveys and Questionnaires 114 Exercise 102 Blood Specimen Collection 98 Radiotherapy 66 Gemcitabine 64 Bevacizumab 57 Cisplatin 55 Standard of Care 54 Cyclophosphamide 51 Capecitabine 50 Carboplatin 49 Docetaxel 47 Dexamethasone 46 pembrolizumab 45 Paclitaxel 45 Interviews as Topic 43 Oxaliplatin 40 Magnetic Resonance Spectroscopy 38 Fluorouracil 37 Methods 36 Irinotecan 36 Therapeutics 33 Drug Therapy 32 Radiosurgery 31 Nivolumab 30 Erlotinib Hydrochloride 27 Educational Status 26 Everolimus 24 Leucovorin 23 Control Groups 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04295447 2024-06-20

ADAM

Universität Münster

Phase 2 Active not recruiting

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡